Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"PHGDH"”.
-
Targeting the PHGDH-mTOR Metabolic Axis in Osteosarcoma
… including 3-phosphoglycerate dehydrogenase (PHGDH), pyruvate kinase M2 (PKM2), serine hydroxymethyltransferase 2 (SHMT2), and methylenetetrahydrofolate dehydrogenase 2 (MTHFD2), have been identified as being overexpressed in a variety of cancers. In particular, given that the de novo …
-
The role of PHGDH in hypoxic adaptation and metabolic reprogramming
… the role of phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme of the serine synthesis pathway (SSP), in hypoxic adaptation and response to radiotherapy. PHGDH expression is induced under severe hypoxia (<0.1% O2). This induction is driven by combined HIF-1 and PERK-ATF4 …
-
Phosphoglycerate Dehydrogenase Regulated by the Mitogen-Activated Protein Kinase Pathway is an Actionable Vulnerability in Cutaneous Melanoma
… project is the Phosphoglycerate Dehydrogenase (PHGDH). The PHGDH gene, encoding the rate-limiting enzyme of the serine synthesis pathway, is located at chromosome locus 1p12 and frequently amplified in melanoma. PHGDH is required for the proliferation of melanoma cells with chromosome 1p12 …
-
Abrogation of serine metabolism exacerbates intestinal epithelial inflammation via C/EBPβ-NF-κB pathway
… enzyme phosphoglycerate dehydrogenase (PHGDH), maintains celular redox balance. Serine metabolism is upregulated in cancer and immune cells, supporting survival and growth. Our previous study showed ER stress mediated rewiring of serine metabolism was a key molecular feature in IBD. …
-
Μελέτη Έκφρασης Εξοκινάσης 2 (HK2) και Αφυδρογονάσης του Φωσφογλυκερικού (PHGDH) σε Κυκλοφορούντα Καρκινικά Κύτταρα Ασθενών με Μη Μικροκυτταρικό Καρκίνο του Πνεύμονα
… φωσφογλυκερικού (Phosphoglycerate Dehydrogenase, PHGDH) είναι το ένζυμο που καταλύει το πρώτο και καθοριστικό βήμα του μονοπατιού SSP και βρίσκεται και αυτό σε υψηλά επίπεδα σε αρκετούς τύπους καρκίνου. Στόχος αυτής της εργασίας ήταν η μελέτη έκφρασης της HK2 και της PHGDH σε κυκλοφορούντα …
-
Endothelial Metabolism in Glioblastoma Vascularity and Resistance to Immunotherapy
… that the enzyme phosphoglycerate dehydrogenase (PHGDH) plays a crucial role in endothelial cell (EC) metabolism, driving the formation of a hypoxic and immune-resistant vascular microenvironment in GBM. This, in turn, leads to a diminished response to CAR-T cell immunotherapy. By conducting …
-
The role of serine metabolism in B lymphocytes
… cell conditional phosphoglycerate dehydrogenase (PHGDH) knockout mice, following immunisation, there was a relative increase in IgG1+ GC B cells. When I activated and cultured B cells from Phgdh KO mouse in vitro, I also found a relative increase in IgG1+ B cells. Phgdh KO mouse B cells did not …
-
Epitranscriptomic regulation in breast cancer and PCB-induced liver disease.
… identified to target two key enzymes (PSAT1 and PHGDH) in the serine biosynthetic pathway (SSP) which is upregulated in ET-resistant BCa cells and in tumors from patients with ET-resistant disease. Using luciferase assays, PSAT1 and PHGDH were validated as bona fide targets of miRNAs …
-
Investigation of phosphoserine aminotransferase 1(PSAT1) in breast cancer progression.
… which was not recapitulated upon suppression of PHGDH, which is the first enzyme within the SSP. I also found that suppression of PSAT1 reduced the number of micro-metastases within the lungs in an experimental metastasis model. In addition, I found that both PSAT1 and PHGDH correlated to poorer …
-
Targeting metabolic dependencies in cancer cells in vitro
… strategy. Phosphoglycerate dehydrogenase (PHGDH), a key enzyme in serine biosynthesis, is frequently overexpressed in LUAD. NCT-503, a PHGDH inhibitor, has emerged as a potential therapeutic agent against LUAD. This study aimed to evaluate the efficacy of NCT-503 in inhibiting cancer cell …
-
Transcriptional, Translational, And Enzymatic Metabolic Regulation By L-2 Hyroxyglutarate
… levels of Phosphoglycerate dehydrogenase (PHGDH) and its transcription factor Activating transcription factor 4 (ATF4). L-2HG transcriptionally represses PHGDH by maintaining histone repressive mark H3K9me3 through inhibiting Lysine demethylase 4C (KDM4C). Further, L-2HG inhibits ATF4 …
-
New insights into the regulation of D-serine and glycine in the central nervous system
… and Srr. 3-phosphoglycerate dehydrogenase (Phgdh) is an exclusively astrocytic enzyme that catalyzes the first committed step of L-serine biosynthesis. Using transgenic mice expressing enhanced green fluorescent protein under the Srr promoter and mice with targeted deletion of Srr or Phgdh, …
-
The relationship between docohexanoic acid (DHA) and L-serine, providing an insight into the biochemistry of meningioma
… 2 (PKM2) and phosphoglycerate dehydrogenase (PHGDH) were shown. Therefore, the results demonstrated that within meningioma tissues, serine can allosterically regulate the flux through glycolysis. The association that serine presence alone can alter the metabolic flux was demonstrated in the …
-
Using CRISPR activation to explore the correlation between metabolic control and cardiomyocyte proliferation
… rate-limiting metabolic genes (PKM2, PHGDH, G6PD, GFPT1, PDK4, HK1 and HK2) were targeted using the dCas9-SunTag system in a mouse cardiomyocyte cell line (HL-1) to select for effective gRNAs by RT-qPCR. One gRNA against each gene was packaged into AAV6 and tested in neonatal …
-
Yeast-based assays for studying the functional impact of missense variants in a rare human disease gene at scale
… disorders caused by pathogenic variants in PHGDH, PSAT1, and PSPH. However, because L-serine supplementation, especially if started early, can ameliorate and in some cases even prevent symptoms, knowledge of pathogenic variants is highly actionable. Here, we use a yeast-based complementation …
-
Metabolism in haematological cancer cells
… agent that depletes exogenous asparagine, with a PHGDH inhibitor (NCT503) had a synergistic effect on the viability in BL cells, exhibiting more decrease in cell viability as compared to those obtained from treatment of ASNase alone. Conversely, the combination of ASNase with NCT503 showed no …
-
STRATEGIES FOR SELECTIVE TARGETING OF THE WARBURG EFFECT IN CANCER
… to target 3-phosphoglycerate dehydrogenase (PHGDH), which diverts glucose flux into serine biosynthesis, and showed that this disrupts cancer cell growth through inhibition of de novo serine synthesis and downstream serine metabolism. Together, my findings contribute to a shifting paradigm in …
-
Evaluating the Role of the Glyoxalase Cycle in Metabolic Disease
… pathway, phosphoglycerate dehydrogenase (PHGDH). Collectively, we demonstrate an important role for non-enzymatic PTMs and how they regulate important cell signaling pathways
-
Trim24 Promotes Mammary Tumor Development By Upregulating Metabolic Reducing Power
… spheroids viability. The effect of PHGDH inhibitor CBR5884, GLS inhibitors CB839, and GCLC inhibitor was enhanced with TRIM24 knock-down, indicating that TRIM24 plays a critical role in oxidation-reduction (REDOX)-related cell survival.</p> <p>Here, with metabolomic studies, we …
-
TRANSLATIONAL RESEARCH TARGETING BILIARY TRACT CANCER
… pathway, including the known regulators PHGDH and PSAT1. Knockdown of PSAT1 was sufficient to replicate synergy with single agent inhibition of either BET or mTOR. Our results tied together epigenetic regulation, metabolism, and apoptosis induction as key therapeutic targets for further …
Page 1 of 2